Wells Fargo
DAWN

Wells Fargo’s Day One Biopharmaceuticals DAWN Stock Holding History

Wells Fargo’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.21M Sell
56,429
-58,287
-51% -$821K ﹤0.01% 3625
2025
Q4 		$1.07M Buy
114,716
+33,248
+41% +$278K ﹤0.01% 3919
2025
Q3 		$574K Buy
81,468
+8,901
+12% +$61.2K ﹤0.01% 4208
2025
Q2 		$472K Buy
72,567
+18,871
+35% +$130K ﹤0.01% 4191
2025
Q1 		$426K Buy
53,696
+1,961
+4% +$21.1K ﹤0.01% 4212
2024
Q4 		$655K Sell
51,735
-4,744
-8% -$66K ﹤0.01% 3999
2024
Q3 		$787K Sell
56,479
-457
-0.8% -$6.52K ﹤0.01% 3694
2024
Q2 		$785K Buy
56,936
+11,175
+24% +$164K ﹤0.01% 3650
2024
Q1 		$756K Buy
45,761
+7,536
+20% +$113K ﹤0.01% 3621
2023
Q4 		$558K Sell
38,225
-39,386
-51% -$477K ﹤0.01% 3787
2023
Q3 		$952K Sell
77,611
-13,350
-15% -$174K ﹤0.01% 3367
2023
Q2 		$1.09M Buy
90,961
+33,403
+58% +$436K ﹤0.01% 3415
2023
Q1 		$770K Buy
57,558
+36,837
+178% +$720K ﹤0.01% 3563
2022
Q4 		$446K Sell
20,721
-258
-1% -$5.29K ﹤0.01% 3712
2022
Q3 		$420K Buy
20,979
+767
+4% +$16.3K ﹤0.01% 3803
2022
Q2 		$362K Buy
20,212
+10,212
+102% +$105K ﹤0.01% 3939
2022
Q1 		$99K Sell
10,000
-652
-6% -$8.61K ﹤0.01% 5337
2021
Q4 		$180K Buy
10,652
+599
+6% +$12.3K ﹤0.01% 5322
2021
Q3 		$238K Buy
+10,053
New +$241K ﹤0.01% 5024

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Wells Fargo's DAWN Position: Q1 2026 in Review

Wells Fargo reduced its Day One Biopharmaceuticals (DAWN) stake by 51% in Q1 2026, selling an estimated $821K and leaving 56,429 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #3625.

Wells Fargo first reported a position in DAWN in Q3 2021 and has held it in 19 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Wells Fargo held 56,429 shares of Day One Biopharmaceuticals worth $1.21M as of Q1 2026.
  • Wells Fargo sold 58,287 Day One Biopharmaceuticals shares in Q1 2026, an estimated $821K.
  • Day One Biopharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3625 holding.
  • Wells Fargo first reported a position in Day One Biopharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.